Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastoma (Jun 2022)
Intrathecal administration of autologous mesenchymal stem cells in multiple system atrophy (Jul 2019)